blue cross cover glp 1 Blue Shield to stop covering popular weight-loss drugs BCBS returns to profit after

, Maclusky, N

Their finding: semaglutide was not detectable in breast milk, and none of the breastfed infants experienced any adverse effects

While these synthetic GLP-1 agonists have demonstrated remarkable efficacy in clinical trials, they are associated with a range of side effects, including common gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation, which are often dose-dependent (Kommu S et al., 2025

Red wine enhances glucosedependent insulinotropic peptide (GIP) and insulin responses in type 2 diabetes during an oral glucose tolerance test

This approach is shaping the future of weight management and chronic disease prevention